In the early stages of breast cancer, TGFB1 functions as a tumor suppressor; however, as the disease advances, its overexpression leads to hyperactivation of the TGFB1 pathway, transitioning its role to that of a tumor promoter thus increasing the risk of cancer development and metastatic progression [102, 103]. This evidence concerns the gene TGFB1 and breast carcinoma.